Last 12 months
Inside the activity.
7 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 1 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2026 Filed Apr 14, 2026 20:06 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002060776-26-000010 · form4-04142026_080442.xml · derivative · entry 3 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested in three equal installments at the close of business on April 12, 2024, April 12, 2025, and April 12, 2026. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested in three equal installments at the close of business on April 12, 2024, April 12, 2025, and April 12, 2026. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested in three equal installments at the close of business on April 12, 2024, April 12, 2025, and April 12, 2026. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · balance_after: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested in three equal installments at the close of business on April 12, 2024, April 12, 2025, and April 12, 2026. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| April 12, 2026 Filed Apr 14, 2026 20:06 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 366 | $4.69 | $1,716.54 |
DisclosureSEC source: 0002060776-26-000010 · form4-04142026_080442.xml · nonDerivative · entry 2 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,688 Read SEC document |
| April 12, 2026 Filed Apr 14, 2026 20:06 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002060776-26-000010 · form4-04142026_080442.xml · nonDerivative · entry 1 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested in three equal installments at the close of business on April 12, 2024, April 12, 2025, and April 12, 2026. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 20:19 UTC |
Dubois Lisa FoleyChief Operating Officer
|
GrantCommon Stock | 14,160 | $0.00 | $0.00 |
DisclosureSEC source: 0002093443-26-000006 · form4-04062026_080404.xml · nonDerivative · entry 1 Dubois Lisa Foley · CIK 0002093443 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,160 F1 · shares: Pursuant to the Agreement and Plan of Merger, dated as of November 24, 2025, by and among the Issuer, The Brand House Collective, Inc. ("TBHC") and Knight Merger Sub II (the "Merger Agreement"), on April 2,2026 (i) each share of TBHC common stock held by the reporting person was cancelled and converted into the right to receive 0.1993 shares (the "Exchange Ratio") of the Issuer's common stock, plus any Fractional Share Consideration, and (ii) each TBHC restricted share unit ("TBHC RSU") became fully vested and was converted into the right to receive the number of shares of the Issuer's common stock equal to the number of shares of TBHC common stock subject to such TBHC RSU multiplied by the Exchange Ratio, plus any Fractional Share Consideration less a number of shares to satisfy tax withholding, as applicable. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 20:13 UTC |
Sullivan Amy ErvinPresident
|
GrantCommon Stock | 95,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001953122-26-000006 · form4-04062026_080410.xml · nonDerivative · entry 1 Sullivan Amy Ervin · CIK 0001953122 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,255 F1 · shares: Pursuant to the Agreement and Plan of Merger, dated as of November 24, 2025, by and among the Issuer, The Brand House Collective, Inc. ("TBHC") and Knight Merger Sub II (the "Merger Agreement"), on April 2,2026 (i) each share of TBHC common stock held by the reporting person was cancelled and converted into the right to receive 0.1993 shares (the "Exchange Ratio") of the Issuer's common stock, plus any Fractional Share Consideration, and (ii) each TBHC restricted share unit ("TBHC RSU") became fully vested and was converted into the right to receive the number of shares of the Issuer's common stock equal to the number of shares of TBHC common stock subject to such TBHC RSU multiplied by the Exchange Ratio, plus any Fractional Share Consideration less a number of shares to satisfy tax withholding, as applicable. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:57 UTC |
Lee AdriannePresident & CFO
|
GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001807266-26-000006 · form4-03122026_100358.xml · derivative · entry 1 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · balance_after: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:19 UTC |
Putnam Leah RChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002060776-26-000007 · form4-03122026_100311.xml · derivative · entry 1 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · balance_after: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 10, 2026 Filed Mar 13, 2026 00:32 UTC |
TABACCO JOSEPH J JRDirector
|
PurchaseCommon Stock | 20,000 | $5.11 | $102,200.00 |
DisclosureSEC source: 0001403544-26-000003 · form4-03132026_120339.xml · nonDerivative · entry 1 TABACCO JOSEPH J JR · CIK 0001403544 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by the Joseph Tabacco and Peggy Schmidt Revocable Trust. Disclosed balance after: 167,209 F1 · price: $5.11 is the weighted average purchase price for the 20,000 shares purchased on March 10, 2026. The shares were purchased in multiple transactions at prices ranging from $5.07 to $5.13 per share, inclusive. The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: Mr. Tabacco is trustee and beneficiary of the Joseph Tabacco and Peggy Schmidt Revocable Trust. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
Exercise / conversionPerformance Shares · Derivative | 141,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · derivative · entry 6 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,868 Underlying: Common Stock · 141,432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. F3 · derivative.exercise_price: (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. F3 · derivative.exercise_date: (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. F3 · derivative.expiration_date: (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. F2 · balance_after: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. F3 · balance_after: (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 166,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · derivative · entry 5 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,334 Underlying: Common Stock · 166,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · balance_after: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
Tax withholdingCommon Stock | 34,680 | $4.91 | $170,278.80 |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · nonDerivative · entry 4 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669,756 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
GrantCommon Stock | 141,432 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · nonDerivative · entry 3 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 704,436 F2 · price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. F3 · price: (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
Tax withholdingCommon Stock | 59,813 | $4.91 | $293,681.83 |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · nonDerivative · entry 2 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,004 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:06 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
GrantCommon Stock | 166,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001136478-26-000006 · form4-03122026_080316.xml · nonDerivative · entry 1 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,817 F1 · price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002060776-26-000004 · form4-03042026_090313.xml · derivative · entry 3 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on March 2, 2024, March 2, 2025 and March 2, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on March 2, 2024, March 2, 2025 and March 2, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on March 2, 2024, March 2, 2025 and March 2, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. F1 · balance_after: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on March 2, 2024, March 2, 2025 and March 2, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 244 | $5.18 | $1,263.92 |
DisclosureSEC source: 0002060776-26-000004 · form4-03042026_090313.xml · nonDerivative · entry 2 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,554 Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002060776-26-000004 · form4-03042026_090313.xml · nonDerivative · entry 1 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on March 2, 2024, March 2, 2025 and March 2, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionPerformance Shares · Derivative | 5,238 | $0.00 | $5.24 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · derivative · entry 12 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,476 Underlying: Common Stock · 5,238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 15,714 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 5,238 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 15,714 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 5,238 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 15,714 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 5,238 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionPerformance Shares · Derivative | 16,072 | $0.00 | $16.07 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · derivative · entry 11 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,144 Underlying: Common Stock · 16,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 48,216 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 16,072 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 48,216 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 16,072 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 48,216 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 16,072 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,172 | $0.00 | $6.17 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · derivative · entry 10 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,225 Underlying: Common Stock · 6,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 18,939 | $0.00 | $18.94 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · derivative · entry 9 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,397 Underlying: Common Stock · 18,939 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted restricted stock units with different vesting schedules. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Tax withholdingCommon Stock | 1,512 | $5.62 | $8,497.44 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 8 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,377 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionCommon Stock | 5,238 | $0.00 | $0.52 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 7 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Tax withholdingCommon Stock | 4,637 | $5.62 | $26,059.94 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 6 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,651 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionCommon Stock | 16,072 | $0.00 | $1.61 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 5 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Tax withholdingCommon Stock | 1,781 | $5.62 | $10,009.22 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 4 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,216 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionCommon Stock | 6,172 | $0.00 | $0.62 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 3 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Tax withholdingCommon Stock | 5,464 | $5.62 | $30,707.68 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 2 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,825 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionCommon Stock | 18,939 | $0.00 | $1.89 |
DisclosureSEC source: 0001807266-26-000004 · form4-02062026_090235.xml · nonDerivative · entry 1 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:09 UTC |
LEMONIS MARCUSDirector · EXECUTIVE CHAIRMAN & CEO
|
GrantPerformance Shares · Derivative | 424,300 | $0.00 | $424.30 |
DisclosureSEC source: 0001136478-26-000002 · form4-02062026_090213.xml · derivative · entry 1 LEMONIS MARCUS · CIK 0001136478 · Director · EXECUTIVE CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,300 Underlying: Common Stock · 424,300 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above. F1 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above. F1 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionPerformance Shares · Derivative | 7,530 | $0.00 | $7.53 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · derivative · entry 12 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,060 Underlying: Common Stock · 7,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 22,590 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 7,530 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 22,590 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 7,530 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 22,590 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 7,530 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionPerformance Shares · Derivative | 1,644 | $0.00 | $1.64 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · derivative · entry 11 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,287 Underlying: Common Stock · 1,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 4,931 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 1,644 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 4,931 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 1,644 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On February 4, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on February 4, 2026, February 4, 2027, and February 4, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 4,931 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 1,644 performance shares) vested on February 4, 2026. The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,929 | $0.00 | $1.93 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · derivative · entry 10 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,166 Underlying: Common Stock · 1,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,811 | $0.00 | $5.81 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · derivative · entry 9 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,095 Underlying: Common Stock · 5,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on February 4, 2026, February 4, 2027 and February 4, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 1,820 | $5.62 | $10,228.40 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 8 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,798 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 7,530 | $0.00 | $0.75 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 7 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 488 | $5.62 | $2,742.56 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 6 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,088 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,644 | $0.00 | $0.16 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 5 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 470 | $5.62 | $2,641.40 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 4 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,932 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,929 | $0.00 | $0.19 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 3 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 1,415 | $5.62 | $7,952.30 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 2 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,473 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:05 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,811 | $0.00 | $0.58 |
DisclosureSEC source: 0002060776-26-000002 · form4-02062026_090204.xml · nonDerivative · entry 1 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 20,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001807266-26-000002 · form4-01272026_090113.xml · derivative · entry 3 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,336 Underlying: Common Stock · 20,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on January 23, 2024, January 23, 2025, and January 23, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on January 23, 2024, January 23, 2025, and January 23, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on January 23, 2024, January 23, 2025, and January 23, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Tax withholdingCommon Stock | 6,049 | $6.87 | $41,556.63 |
DisclosureSEC source: 0001807266-26-000002 · form4-01272026_090113.xml · nonDerivative · entry 2 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,350 Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:06 UTC |
Lee AdriannePresident & CFO
|
Exercise / conversionCommon Stock | 20,965 | $0.00 | $2.10 |
DisclosureSEC source: 0001807266-26-000002 · form4-01272026_090113.xml · nonDerivative · entry 1 Lee Adrianne · CIK 0001807266 · President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0002060776-25-000007 · form4-11182025_091116.xml · derivative · entry 3 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,906 Underlying: Common Stock · 1,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Tax withholdingCommon Stock | 289 | $6.03 | $1,742.67 |
DisclosureSEC source: 0002060776-25-000007 · form4-11182025_091116.xml · nonDerivative · entry 2 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,077 Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:07 UTC |
Putnam Leah RChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,186 | $0.00 | $0.12 |
DisclosureSEC source: 0002060776-25-000007 · form4-11182025_091116.xml · nonDerivative · entry 1 Putnam Leah R · CIK 0002060776 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:06 UTC |
Thomas Alexander WilliamChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0002060661-25-000008 · form4-11182025_091158.xml · derivative · entry 4 Thomas Alexander William · CIK 0002060661 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,143 Underlying: Common Stock · 1,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:06 UTC |
Thomas Alexander WilliamChief Operating Officer
|
Tax withholdingCommon Stock | 343 | $6.03 | $2,068.29 |
DisclosureSEC source: 0002060661-25-000008 · form4-11182025_091158.xml · nonDerivative · entry 2 Thomas Alexander William · CIK 0002060661 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,793 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.